Marina Spanos

Marina Spanos

Auto-generated profile, based on publicly available information

Marina Spanos

Department of Psychiatry and Behavioral Sciences, Duke University, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2023 in Autism Research
Verified
Journal Article
Open access
SSStephen K. Siecinski
Stephen K. Siecinski
SGStephanie Giamberardino
Stephanie Giamberardino
MSMarina Spanos
Marina Spanos
AHAnnalise C. Hauser
Annalise C. Hauser
JGJason R. Gibson
Jason R. Gibson
SGSimon G. Gregory
Simon G. Gregory
Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) have reported mixed results due in part to ASD's complex etiology. We investigated whether genetic and epigenetic variation contribute to variable endogenous OT levels that modulate sensitivity to OT therapy. To carry out this analysis, we integrated genome‐wide profiles of DNA‐methylation, transcriptional activity, and genetic variation with plasma OT levels in 290 participants with ASD enrolled in a randomized controlled trial of OT. Our analysis identified genetic variants with novel association with plasma OT, several of which reside in known ASD risk genes. We also show subtle but statistically significant association of plasma OT levels with peripheral transcriptional activity and DNA‐methylation profiles across several annotated gene sets. These findings broaden our understanding of the effects of the peripheral oxytocin system and provide novel genetic candidates for future studies to decode the complex etiology of ASD and its interaction with OT signaling and OT‐based interventions.Lay Summary: Oxytocin (OT) is an abundant chemical produced by neurons that plays an important role in social interaction and motivation. We investigated whether genetic and epigenetic factors contribute to variable OT levels in the blood. To this, we integrated genetic, gene expression, and non‐DNA regulated (epigenetic) signatures with blood OT levels in 290 participants with autism enrolled in an OT clinical trial. We identified genetic association with plasma OT, several of which reside in known autism risk genes. We also show statistically significant association of plasma OT levels with gene expression and epigenetic across several gene pathways. These findings broaden our understanding of the factors that influence OT levels in the blood for future studies to decode the complex presentation of autism and its interaction with OT and OT‐based treatment.

26 September 2024 in NEJM AI
Verified
Journal Article
Closed access
PBPradeep Raj Krishnappa Babu
Pradeep Raj Krishnappa Babu
JMJ. Matias Di Martino
J. Matias Di Martino
RARachel Aiello
Rachel Aiello
BEBrian Eichner
Brian Eichner
SESteven Espinosa
Steven Espinosa
GSGuillermo Sapiro
Guillermo Sapiro
Early detection of autism is important for timely access to diagnostic evaluation and early intervention services, which improve children's outcomes. Despite the ability of clinicians to reliably diagnose autism in toddlers, diagnosis is often delayed. SenseToKnow is a mobile autism screening application (app) delivered on a smartphone or tablet that provides an objective and quantitative assessment of early behavioral signs of autism based on computer vision (CV) and machine learning (ML). This study examined the accuracy of SenseToKnow for autism detection when the app was downloaded and administered remotely at home by caregivers using their own devices. The SenseToKnow app was administered by caregivers of 620 toddlers between 16 and 40 months of age, 188 of whom were subsequently diagnosed with autism by expert clinicians. The app displayed strategically designed movies and a bubble-popping game on an iPhone or iPad while recording the child's behavioral responses through the device's front-facing camera and touch/inertial sensors. Recordings of the child's behavior were then automatically analyzed using CV. Multiple behavioral phenotypes were quantified and combined using ML in an algorithm for autism prediction. SenseToKnow demonstrated a high level of diagnostic accuracy with area under the receiver operating characteristic curve of 0.92, sensitivity of 83.0%, specificity of 93.3%, positive predictive value of 84.3%, and negative predictive value of 92.6%. Accuracy of the app for detecting autism was similar when administered on either a caregiver's iPhone or iPad. These results demonstrate that a mobile autism screening app based on CV can be delivered remotely by caregivers at home on their own devices and can provide a high level of accuracy for autism detection. Remote screening for autism potentially lowers barriers to autism screening, which could reduce disparities in early access to services and support and improve children's outcomes.

1 October 2021 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
MSMarina Spanos
Marina Spanos
TBTerrence Bethea
Terrence Bethea
CACheryl Alderman
Cheryl Alderman
JJJacqueline Johnson
Jacqueline Johnson
TCTara Chandrasekhar
Tara Chandrasekhar
LSLinmarie Sikich
Linmarie Sikich

13 October 2024
Verified
Conference Paper
Open access
VAVikram Aikat
Vikram Aikat
PBPradeep Raj Krishnappa Babu
Pradeep Raj Krishnappa Babu
KCKimberly L.H. Carpenter
Kimberly L.H. Carpenter
JMJ. Matias Di Martino
J. Matias Di Martino
SESteven Espinosa
Steven Espinosa
GSGuillermo Sapiro
Guillermo Sapiro
The high prevalence of autism calls for accessible and scalable technology-assisted screening tools. This will aid in early detection allowing timely access to services and supports. SenseToKnow, a mobile digital phenotyping app, showed potential in eliciting autism-related behaviors that can be automatically captured via computer vision analysis (CVA) in toddlers. Here, we present the capability of SenseToKnow in characterizing autism in school age children and showcase the robustness of the CVA features in interpreting distinct and overlapping behaviors with attention-deficit/hyperactive disorder (ADHD).

12 July 2024 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
JMJane Marryat
Jane Marryat
NDNaomi O. Davis
Naomi O. Davis
RLReginald Lerebours
Reginald Lerebours
KCKimberly L. H. Carpenter
Kimberly L. H. Carpenter
SCScott Compton
Scott Compton
GDGeraldine Dawson
Geraldine Dawson